Every six seconds a person dies of diabetes. Diabetes caused 5.1 million deaths in 2013. Indigenous communities are among those especially vulnerable to diabetes. No countries are escaping the diabetes epidemic, and in states worldwide it is the poor and disadvantaged who are suffering most. With an increasing incidence worldwide, DM will be a leading cause of morbidity and mortality in the predictable future. It also predisposes to cardiovascular diseases. 4ĭiabetes is the leading cause of end-stage renal disease (ESRD), non-traumatic lower extremity amputations, and adult blindness. The prevalence of these complications of diabetes is generally expected to be proportional to the duration of diabetes and the degree of glycemic control. 1– 3Īs it is a progressive disease, diabetic patients are frequently diagnosed with chronic complications including cardiovascular disease, nephropathy, coronary heart disease, retinopathy, and neuropathy. Even with the great steps that have been made in the understanding and management of type 2 diabetes, insulin resistance, and diabetes-related complications are increasing unrelieved. This form of diabetes generally begins as insulin resistance and, because the body is unable to produce enough insulin to address the resistance, the pancreas may reduce the production of insulin or in the long run stop producing it. Type 2 diabetes accounts for 90–95% of all diagnosed diabetes cases. As of yet, there are no known ways to prevent type 1 diabetes. Type 1 diabetes accounts for 5–10% of all cases of diabetes. There are two main forms of diabetes, type 1 (insulin-dependent diabetes mellitus) and type 2 (non-insulin-dependent diabetes mellitus). Keywords: diabetic complication, glycaemic control, adherenceĭiabetes mellitus (DM) is a group of common metabolic disorders that share the phenotype of hyperglycemia, and are caused by an interaction of genetics and environmental factors. Clinicians should implement a comprehensive care plan that will address patients’ adherence and glycemic control problems. Poor glycemic control, poor adherence, and income were found to be modifiable determinants on the other hand, age and type of diabetic mellitus are non-modifiable determinants of diabetic complications. Of these respondents, 57.4% and 57.8% were males and type 1 diabetic patients, respectively.
Results: Of the total respondents, 68 were cases and 136 were controls, with an overall response rate of 98.55%.
For multivariable analysis, a backward model was selected and 95% confidence interval variables with P-values below 0.05 in multivariable analysis were declared as significant variables.
In bivariate analysis, variables below 0.25 significance level were selected for multivariable analysis. Descriptive analysis including mean, median and proportions was carried out.
Data were entered into EPI-data 3.1 software and exported to SPSS version 21 for analysis. Data were collected from 204 individuals, 136 controls and 68 cases using an interviewer-administered questionnaire and patient chart. Methods: A hospital-based unmatched case control study was conducted from February 2018 to April 2018 at Debre Markos Referral Hospital. Diabetes mellitus produces change in the blood vessels and therefore affects almost every part of the body. Bekalu Bewket Kidanie, 1 Girma Alem, 1 Haymanot Zeleke, 1 Mihretie Gedfew, 1 Afework Edemealem, 2 Atsedemariam Andualem 2ġDepartment of Nursing, College of Health Science, Debre Markos University, Debre Markos, Ethiopia 2Department of Nursing, College of Health Science, Wollo University, Dessie, Ethiopiaĭepartment of Nursing, College of Health Science, Debre Markos University, Debre Markos, Ethiopiaīackground: Diabetes mellitus is a group of common metabolic disorders that share the phenotype of hyperglycemia, and are caused by a complex interaction of genetics and environmental factors.